PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.

Yiqing Huang, Junyi Zhou, Kezhi Zhou,Biao Huang,Jing Xue,Xiran Zhang,Bin Liu,Zhijian Zhang,Leting Zhou,Ting Cai,Yi Zhang,Zhigang Hu,Liang Wang,Xiaobin Liu

PeerJ（2022）

引用 0|浏览9

暂无评分

摘要

We found that the patients in the RTX group and CTX group achieved effective remission of proteinuria after 12 months of treatment. PLA2R-IgG4 may be a more effective biomarker for treatment effectiveness analysis and prognostic assessment, compared with anti-PLA2R-IgG for PLA2R associated IMN.

查看译文

关键词

Idiopathic membranous nephropathy,IgG4,M-type phospholipase A2 receptor,Rituximab,Time-resolved fluoroimmunoassay

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要